• 1
    Abrams P, Cardozo L, Fall M, et al. The standardization of terminology of lower urinary tract function: report from the standardization sub-committee of the International Continence Society. Neurourol Urodyn 2002;21: 16778.
  • 2
    Grimby A, Milsom I, Molander U, et al. The influence of urinary incontinence on the quality of life of elderly women. Age Ageing 1993;22: 829.
  • 3
    Hunskaar S, Vinsnes A. The quality of life in women with urinary incontinence as measured by the sickness impact profile. J Am Geriatr Soc 1991;39: 37882.
  • 4
    Kobelt G, Kirchberger I, Malone-Lee J. Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine. BJU Int 1998; 83: 58390.
  • 5
    O'Conor R, Johannesson M, Hass S, Kobelt-Nguyen G. Urge incontinence: quality of life and patients’ valuation of symptom reduction. Pharmacoeconomics 1998;14: 5319.
  • 6
    Wyman J, Harkins S, Choi S, et al. Psychosocial impact of urinary incontinence in women. Obstet Gynecol 1987;70: 37881.
  • 7
    Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003;20: 32736.
  • 8
    Milsom I, Abrams P, Cardozo L, et al. How widespread are the symptoms of an overactive bladder and how are the managed? A population-based prevalence study. BJU Int 2001;87: 7606.
  • 9
    Robinson D, Pearce K, Preisser J, et al. Relationship between patient reports of urinary incontinence symptoms and quality of life measures. Obstet Gynecol 1998;91: 2248.
  • 10
    Norton PA, MacDonald LD, Sedgwick PM, et al. Distress and delay associated with urinary incontinence, frequency, and urgency in women. BMJ 1998;297: 11879.
  • 11
    Liberman JN, Hunt TL, Stewart WF, et al. Health-related quality-of-life among adults with symptoms of overactive bladder: results from a US community-based survey. Urology 2001;57: 104450.
  • 12
    Coyne KS, Revicki DA, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 2002;11: 56374.
  • 13
    Ware JE, Snow KK, Kosinski M, et al. SF-36 Health Survey Manual and Interpretation Guide. Boston: New England Medical Center, The Health Institute, 1993.
  • 14
    Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1: 385401.
  • 15
    Radloff LS, Teri L. Use of the center for epidemiological studies-depression scale with older adults. Clin Gerontol 1986;5: 11936.
  • 16
    Lyness JM, Noel TK, Cox C, et al. Screening for depression in elderly primary care patients: a comparison of the center for epidemiologic studies-depression scale and the geriatric depression scale. Arch Intern Med 1997;157: 44954.
  • 17
    Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998;50: 18426.
  • 18
    Payne R, Mathias SD, Pasta DJ, et al. Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine. J Clin Oncol 1998;16: 158893.
  • 19
    Hays RD, Stewart AL. Sleep measures. In: StewartAL, WareJE Jr, eds., Measuring Functioning and Well-Being: the Medical Outcomes Study Approach. Durham (NC): Duke University Press, 1992.
  • 20
    Belsley DA, Kuh E, Welsch RE. Regression Diagnostics: Identifying Influential Data and Sources of Collinearity. New York: John Wiley & Sons, 1980.
  • 21
    Brown JS, Vittinghoff E, Wyman JF, et al. Urinary incontinence: does it increase risk for falls and fractures? J Am Geriatr Soc 2000;487: 7215.
  • 22
    Zorn BH, Montgomery H, Pieper K, et al. Urinary incontinence and depression. J Urol 1999;102: 824.
  • 23
    Jolleys JV, Donovan JL, Nanchahal K, et al. Urinary symptoms in the community: how bothersome are they? Br J Urol 1994;74: 5515.
  • 24
    Samuelsson E, Victor A, Tibblin G. A population study of urinary incontinence and nocturia among women aged 20–59 years. Acta Obstet Gynecol Scand 1997;76: 7480.
  • 25
    Leidy NK, Revicki DA, Geneste B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 1999;2: 11327.
  • 26
    Revicki DA, Osoba D, Fairclough D, et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000;9: 887900.
  • 27
    Santanello NC, Baker D, Cappelleri JC, et al. Regulatory issues for health-related quality of life—PhRMA Health Outcomes Committee workshop, 1999. Value Health 2002;5: 1425.